Tidal Trust III - VistaShares人工智慧超級週期ETF
US ˙ ARCA

簡介

本頁面提供了有關 Thomas J Garrity 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Thomas J Garrity已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:ATRS / Antares Pharma Inc Director 0
如何解讀這些圖表

以下圖表顯示了在Thomas J Garrity進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF內部人士買入 - 短期收益分析

在這一部分,我們分析了在 AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
2016-03-18 ATRS GARRITY THOMAS J 30,000 0.7200 30,000 0.7200 21,600 363 2.82 63,000 291.67
2014-08-11 ATRS GARRITY THOMAS J 5,000 1.9800 5,000 1.9800 9,900

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF Insider Trades
AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
2019-12-09 ATRS GARRITY THOMAS J 40,000 4.5809 40,000 4.5809 183,236 100 1.75 -113,236 -61.80
2019-12-09 ATRS GARRITY THOMAS J 40,000 4.5809 40,000 4.5809 183,236
2013-05-31 ATRS GARRITY THOMAS J 13,000 4.0770 13,000 4.0770 53,001
2012-08-20 ATRS GARRITY THOMAS J 31,000 4.0151 31,000 4.0151 124,468

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF Insider Trades
歷史內部人交易

該表格顯示了由 Thomas J Garrity 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
D - Sale to Issuer -48,542 0 -100.00
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
D - Sale to Issuer -58,246 0 -100.00
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
D - Sale to Issuer -46,729 0 -100.00
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
D - Sale to Issuer -76,548 0 -100.00
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
D - Sale to Issuer -80,318 0 -100.00
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
D - Sale to Issuer -99,395 0 -100.00
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
D - Sale to Issuer -61,930 0 -100.00
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Common Stock
D - Sale to Issuer -25,452 0 -100.00 5.60 -142,531
2022-05-26 2022-05-24 4 ATRS ANTARES PHARMA, INC.
Common Stock
D - Sale to Issuer -224,406 0 -100.00 5.60 -1,256,674
2021-06-14 2021-06-10 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
A - Award 48,542 48,542
2021-06-14 2021-06-10 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 25,452 249,858 11.34 4.42 112,498 1,104,372
2021-03-12 2021-03-11 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -50,000 0 -100.00
2021-03-12 2021-03-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -50,000 224,406 -18.22 4.28 -214,000 960,458
2021-03-12 2021-03-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 50,000 274,406 22.28 1.12 56,000 307,335
2021-02-12 2021-02-11 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -50,000 0 -100.00
2021-02-12 2021-02-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -50,000 224,406 -18.22 4.62 -231,000 1,036,756
2021-02-12 2021-02-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 50,000 274,406 22.28 1.12 56,000 307,335
2021-01-13 2021-01-11 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -50,000 0 -100.00
2021-01-13 2021-01-11 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -20,000 0 -100.00
2021-01-13 2021-01-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -50,000 224,406 -18.22 4.05 -202,500 908,844
2021-01-13 2021-01-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 50,000 274,406 22.28 1.12 56,000 307,335
2021-01-13 2021-01-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -20,000 224,406 -8.18 4.07 -81,400 913,332
2021-01-13 2021-01-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 20,000 244,406 8.91 2.24 44,800 547,469
2020-06-15 2020-06-11 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
A - Award 58,246 58,246
2020-06-15 2020-06-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 30,220 224,406 15.56 2.73 82,501 612,628
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise -40,000 0 -100.00
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise -40,000 0 -100.00
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -40,000 194,186 -17.08 4.58 -183,236 889,547
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -40,000 194,186 -17.08 4.58 -183,236 889,547
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 40,000 234,186 20.60 1.66 66,400 388,749
2019-12-11 2019-12-09 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 40,000 234,186 20.60 1.60 64,000 374,698
2019-11-04 2019-11-01 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise -10,000 0 -100.00
2019-11-04 2019-11-01 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 10,000 194,186 5.43 1.10 11,000 213,605
2019-06-14 2019-06-13 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
A - Award 46,729 46,729
2019-06-14 2019-06-13 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 23,973 184,186 14.96 2.92 70,001 537,823
2019-05-03 2019-05-01 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -30,000 0 -100.00
2019-05-03 2019-05-01 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -30,000 160,213 -15.77 2.67 -79,968 427,064
2019-05-03 2019-05-01 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 30,000 190,213 18.73 0.53 15,900 100,813
2018-06-11 2018-06-08 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
A - Award 76,548 76,548
2017-10-05 2017-10-03 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -30,000 0 -100.00
2017-10-05 2017-10-03 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -30,000 160,213 -15.77 3.50 -105,000 560,746
2017-10-05 2017-10-03 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 30,000 190,213 18.73 0.85 25,500 161,681
2017-06-09 2017-06-07 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
A - Award 80,318 80,318
2017-04-04 2017-03-31 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
M - Exercise X -30,000 0 -100.00
2017-04-04 2017-03-31 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale X -30,000 160,213 -15.77 2.91 -87,276 466,092
2017-04-04 2017-03-31 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise X 30,000 190,213 18.73 1.65 49,500 313,851
2016-06-06 2016-06-02 4 ATRS ANTARES PHARMA, INC.
Stock Option (right to buy)
A - Award 150,000 150,000
2016-03-21 2016-03-18 4 ATRS ANTARES PHARMA, INC.
Common Stock
P - Purchase 30,000 160,213 23.04 0.72 21,600 115,353
2015-06-01 2015-05-28 4 ATRS ANTARES PHARMA, INC.
Stock option (right to buy)
A - Award 99,395 99,395
2014-08-13 2014-08-11 4 ATRS ANTARES PHARMA, INC.
Common Stock
P - Purchase 5,000 130,213 3.99 1.98 9,900 257,822
2014-06-02 2014-05-29 4 ATRS ANTARES PHARMA, INC.
Stock option (right to buy)
A - Award 61,930 261,930 30.96
2013-06-03 2013-05-31 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -13,000 125,213 -9.41 4.08 -53,001 510,493
2013-05-24 2013-05-22 4 ATRS ANTARES PHARMA, INC.
Common Stock
A - Award 27,778 138,213 25.15
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
S - Sale -31,000 110,435 -21.92 4.02 -124,468 443,408
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Employee Stock Option (right to buy)
M - Exercise -500 0 -100.00
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Employee Stock Option (right to buy)
M - Exercise -500 0 -100.00
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Employee Stock Option (right to buy)
M - Exercise -2,000 0 -100.00
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Employee Stock Option (right to buy)
M - Exercise -2,000 0 -100.00
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Employee Stock Option (right to buy)
M - Exercise -500 0 -100.00
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Employee Stock Option (right to buy)
M - Exercise -1,000 0 -100.00
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Employee Stock Option (right to buy)
M - Exercise -500 0 -100.00
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Employee Stock Option (right to buy)
M - Exercise -18,000 0 -100.00
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Employee Stock Option (right to buy)
M - Exercise -500 0 -100.00
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Employee Stock Option (right to buy)
M - Exercise -6,750 0 -100.00
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -166 103,741 -0.16 3.97 -659 411,852
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 500 103,907 0.48 1.32 660 137,157
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -705 103,407 -0.68 3.97 -2,799 410,526
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 2,000 104,112 1.96 1.40 2,800 145,757
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -183 102,112 -0.18 3.97 -727 405,385
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 500 102,295 0.49 1.45 725 148,328
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -335 101,795 -0.33 3.97 -1,330 404,126
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 1,000 102,130 0.99 1.33 1,330 135,833
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -554 101,130 -0.54 3.97 -2,199 401,486
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 2,000 101,684 2.01 1.10 2,200 111,852
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -134 99,684 -0.13 3.97 -532 395,745
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 500 99,818 0.50 1.06 530 105,807
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -4,806 99,318 -4.62 3.97 -19,080 394,292
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 18,000 104,124 20.90 1.06 19,080 110,371
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -142 86,124 -0.16 3.97 -564 341,912
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 500 86,266 0.58 1.13 565 97,481
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -188 85,766 -0.22 3.97 -746 340,491
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 500 85,954 0.59 1.49 745 128,071
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -2,210 85,454 -2.52 3.97 -8,774 339,252
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 6,750 87,664 8.34 1.30 8,775 113,963
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Employee Stock Option (right to buy)
M - Exercise -10,000 0 -100.00
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Employee Stock Option (right to buy)
M - Exercise -20,000 0 -100.00
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Employee Stock Option (right to buy)
M - Exercise -20,000 0 -100.00
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Employee Stock Option (right to buy)
M - Exercise -1,250 0 -100.00
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Employee Stock Option (right to buy)
M - Exercise -1,250 0 -100.00
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Employee Stock Option (right to buy)
M - Exercise -1,000 0 -100.00
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Employee Stock Option (right to buy)
M - Exercise -2,000 0 -100.00
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Employee Stock Option (right to buy)
M - Exercise -2,000 0 -100.00
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Employee Stock Option (right to buy)
M - Exercise -500 0 -100.00
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Employee Stock Option (right to buy)
M - Exercise -500 0 -100.00
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -3,904 141,435 -2.69 3.97 -15,499 561,497
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 10,000 145,339 7.39 1.55 15,500 225,275
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -7,758 135,339 -5.42 3.97 -30,799 537,296
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 20,000 143,097 16.25 1.54 30,800 220,369
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -7,053 123,097 -5.42 3.97 -28,000 488,695
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 20,000 130,150 18.16 1.40 28,000 182,210
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -441 110,150 -0.40 3.97 -1,751 437,296
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 1,250 110,591 1.14 1.40 1,750 154,827
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -220 109,341 -0.20 3.97 -873 434,084
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 1,250 109,561 1.15 0.70 875 76,693
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -227 108,311 -0.21 3.97 -901 429,995
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 1,000 108,538 0.93 0.90 900 97,684
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -453 107,538 -0.42 3.97 -1,798 426,926
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 2,000 107,991 1.89 0.90 1,800 97,192
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -120 105,991 -0.11 3.97 -476 420,784
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 500 106,111 0.47 0.95 475 100,805
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -121 105,611 -0.11 3.97 -480 419,276
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 500 105,732 0.48 0.96 480 101,503
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
F - Taxes -509 105,232 -0.48 3.97 -2,021 417,771
2012-08-22 2012-08-20 4 ATRS ANTARES PHARMA, INC.
Common Stock
M - Exercise 2,000 105,741 1.93 1.01 2,020 106,798
2012-05-21 2012-05-17 4 AIS ANTARES PHARMA, INC.
Common Stock
A - Award 30,914 80,914 61.83
2006-05-05 2006-05-03 4 ANTR ANTARES PHARMA INC
Stock Option (right to buy)
A - Award 10,000 10,000
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)